CVS Group plc

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, ROL has a market cap of 27.49B. Regarding current trading prices, CVSGF is priced at $17.10, while ROL trades at $56.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas ROL's P/E ratio is 57.29. In terms of profitability, CVSGF's ROE is +0.06%, compared to ROL's ROE of +0.36%. Regarding short-term risk, CVSGF is less volatile compared to ROL. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, SCI has a market cap of 10.80B. Regarding current trading prices, CVSGF is priced at $17.10, while SCI trades at $75.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas SCI's P/E ratio is 20.95. In terms of profitability, CVSGF's ROE is +0.06%, compared to SCI's ROE of +0.33%. Regarding short-term risk, CVSGF is less volatile compared to SCI. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, HRB has a market cap of 7.72B. Regarding current trading prices, CVSGF is priced at $17.10, while HRB trades at $57.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas HRB's P/E ratio is 16.19. In terms of profitability, CVSGF's ROE is +0.06%, compared to HRB's ROE of -1.99%. Regarding short-term risk, CVSGF is less volatile compared to HRB. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, BFAM has a market cap of 7.00B. Regarding current trading prices, CVSGF is priced at $17.10, while BFAM trades at $121.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas BFAM's P/E ratio is 44.04. In terms of profitability, CVSGF's ROE is +0.06%, compared to BFAM's ROE of +0.12%. Regarding short-term risk, CVSGF is less volatile compared to BFAM. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, FTDR has a market cap of 3.91B. Regarding current trading prices, CVSGF is priced at $17.10, while FTDR trades at $53.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas FTDR's P/E ratio is 17.30. In terms of profitability, CVSGF's ROE is +0.06%, compared to FTDR's ROE of +1.04%. Regarding short-term risk, CVSGF is less volatile compared to FTDR. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, BYDGF has a market cap of 3.20B. Regarding current trading prices, CVSGF is priced at $17.10, while BYDGF trades at $149.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas BYDGF's P/E ratio is 132.07. In terms of profitability, CVSGF's ROE is +0.06%, compared to BYDGF's ROE of +0.03%. Regarding short-term risk, CVSGF and BYDGF have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, DSEY has a market cap of 2.72B. Regarding current trading prices, CVSGF is priced at $17.10, while DSEY trades at $8.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas DSEY's P/E ratio is -14.47. In terms of profitability, CVSGF's ROE is +0.06%, compared to DSEY's ROE of -0.23%. Regarding short-term risk, CVSGF is less volatile compared to DSEY. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, MCW has a market cap of 2.42B. Regarding current trading prices, CVSGF is priced at $17.10, while MCW trades at $7.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas MCW's P/E ratio is 31.04. In terms of profitability, CVSGF's ROE is +0.06%, compared to MCW's ROE of +0.08%. Regarding short-term risk, CVSGF is less volatile compared to MCW. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, ROVR has a market cap of 2.00B. Regarding current trading prices, CVSGF is priced at $17.10, while ROVR trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas ROVR's P/E ratio is 183.25. In terms of profitability, CVSGF's ROE is +0.06%, compared to ROVR's ROE of +0.04%. Regarding short-term risk, CVSGF is less volatile compared to ROVR. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, PRRWF has a market cap of 655.42M. Regarding current trading prices, CVSGF is priced at $17.10, while PRRWF trades at $19.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas PRRWF's P/E ratio is -91.33. In terms of profitability, CVSGF's ROE is +0.06%, compared to PRRWF's ROE of -0.01%. Regarding short-term risk, CVSGF is less volatile compared to PRRWF. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, CSV has a market cap of 651.41M. Regarding current trading prices, CVSGF is priced at $17.10, while CSV trades at $41.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas CSV's P/E ratio is 13.88. In terms of profitability, CVSGF's ROE is +0.06%, compared to CSV's ROE of +0.23%. Regarding short-term risk, CVSGF is less volatile compared to CSV. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, CRLKP has a market cap of 456.62M. Regarding current trading prices, CVSGF is priced at $17.10, while CRLKP trades at $20.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas CRLKP's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to CRLKP's ROE of +0.43%. Regarding short-term risk, CVSGF and CRLKP have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, MED has a market cap of 140.36M. Regarding current trading prices, CVSGF is priced at $17.10, while MED trades at $12.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas MED's P/E ratio is -19.95. In terms of profitability, CVSGF's ROE is +0.06%, compared to MED's ROE of -0.03%. Regarding short-term risk, CVSGF is less volatile compared to MED. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, EM has a market cap of 115.32M. Regarding current trading prices, CVSGF is priced at $17.10, while EM trades at $1.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas EM's P/E ratio is -106.50. In terms of profitability, CVSGF's ROE is +0.06%, compared to EM's ROE of -0.01%. Regarding short-term risk, CVSGF and EM have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, WOSSF has a market cap of 95.28M. Regarding current trading prices, CVSGF is priced at $17.10, while WOSSF trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas WOSSF's P/E ratio is 14.00. In terms of profitability, CVSGF's ROE is +0.06%, compared to WOSSF's ROE of +0.22%. Regarding short-term risk, CVSGF is less volatile compared to WOSSF. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, EDEMY has a market cap of 81.64M. Regarding current trading prices, CVSGF is priced at $17.10, while EDEMY trades at $68.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas EDEMY's P/E ratio is 18.91. In terms of profitability, CVSGF's ROE is +0.06%, compared to EDEMY's ROE of +0.16%. Regarding short-term risk, CVSGF and EDEMY have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, MNLXF has a market cap of 75.84M. Regarding current trading prices, CVSGF is priced at $17.10, while MNLXF trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas MNLXF's P/E ratio is -7.86. In terms of profitability, CVSGF's ROE is +0.06%, compared to MNLXF's ROE of +1.98%. Regarding short-term risk, CVSGF and MNLXF have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, XSPA has a market cap of 54.52M. Regarding current trading prices, CVSGF is priced at $17.10, while XSPA trades at $0.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas XSPA's P/E ratio is 21.83. In terms of profitability, CVSGF's ROE is +0.06%, compared to XSPA's ROE of -0.49%. Regarding short-term risk, CVSGF is less volatile compared to XSPA. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, YYGH has a market cap of 48.96M. Regarding current trading prices, CVSGF is priced at $17.10, while YYGH trades at $1.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas YYGH's P/E ratio is -9.14. In terms of profitability, CVSGF's ROE is +0.06%, compared to YYGH's ROE of -0.78%. Regarding short-term risk, CVSGF is less volatile compared to YYGH. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, RGS has a market cap of 46.55M. Regarding current trading prices, CVSGF is priced at $17.10, while RGS trades at $19.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas RGS's P/E ratio is 0.52. In terms of profitability, CVSGF's ROE is +0.06%, compared to RGS's ROE of +2.66%. Regarding short-term risk, CVSGF is less volatile compared to RGS. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, WW has a market cap of 31.36M. Regarding current trading prices, CVSGF is priced at $17.10, while WW trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas WW's P/E ratio is -0.09. In terms of profitability, CVSGF's ROE is +0.06%, compared to WW's ROE of +0.31%. Regarding short-term risk, CVSGF is less volatile compared to WW. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, KVIL has a market cap of 30.53M. Regarding current trading prices, CVSGF is priced at $17.10, while KVIL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas KVIL's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to KVIL's ROE of N/A. Regarding short-term risk, CVSGF and KVIL have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, EJH has a market cap of 19.09M. Regarding current trading prices, CVSGF is priced at $17.10, while EJH trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas EJH's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to EJH's ROE of -0.15%. Regarding short-term risk, CVSGF is less volatile compared to EJH. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, GDDFF has a market cap of 10.31M. Regarding current trading prices, CVSGF is priced at $17.10, while GDDFF trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas GDDFF's P/E ratio is -3.50. In terms of profitability, CVSGF's ROE is +0.06%, compared to GDDFF's ROE of +0.26%. Regarding short-term risk, CVSGF and GDDFF have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, MRM has a market cap of 6.72M. Regarding current trading prices, CVSGF is priced at $17.10, while MRM trades at $0.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas MRM's P/E ratio is 4.25. In terms of profitability, CVSGF's ROE is +0.06%, compared to MRM's ROE of +1.47%. Regarding short-term risk, CVSGF is less volatile compared to MRM. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, TRNR has a market cap of 6.15M. Regarding current trading prices, CVSGF is priced at $17.10, while TRNR trades at $0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas TRNR's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to TRNR's ROE of -13.46%. Regarding short-term risk, CVSGF is less volatile compared to TRNR. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, XWEL has a market cap of 4.63M. Regarding current trading prices, CVSGF is priced at $17.10, while XWEL trades at $0.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas XWEL's P/E ratio is -0.24. In terms of profitability, CVSGF's ROE is +0.06%, compared to XWEL's ROE of -2.71%. Regarding short-term risk, CVSGF is less volatile compared to XWEL. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, IVP has a market cap of 3.39M. Regarding current trading prices, CVSGF is priced at $17.10, while IVP trades at $1.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas IVP's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to IVP's ROE of -32.65%. Regarding short-term risk, CVSGF is less volatile compared to IVP. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, GDET has a market cap of 89921.00. Regarding current trading prices, CVSGF is priced at $17.10, while GDET trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas GDET's P/E ratio is -0.10. In terms of profitability, CVSGF's ROE is +0.06%, compared to GDET's ROE of +0.00%. Regarding short-term risk, CVSGF and GDET have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, BZRT has a market cap of 53492.00. Regarding current trading prices, CVSGF is priced at $17.10, while BZRT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas BZRT's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to BZRT's ROE of N/A. Regarding short-term risk, CVSGF and BZRT have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, AIOM has a market cap of 34000.00. Regarding current trading prices, CVSGF is priced at $17.10, while AIOM trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas AIOM's P/E ratio is -0.03. In terms of profitability, CVSGF's ROE is +0.06%, compared to AIOM's ROE of +0.00%. Regarding short-term risk, CVSGF is less volatile compared to AIOM. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, PTTL has a market cap of 25350.00. Regarding current trading prices, CVSGF is priced at $17.10, while PTTL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas PTTL's P/E ratio is -0.01. In terms of profitability, CVSGF's ROE is +0.06%, compared to PTTL's ROE of N/A. Regarding short-term risk, CVSGF and PTTL have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, AMIH has a market cap of 19500.00. Regarding current trading prices, CVSGF is priced at $17.10, while AMIH trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas AMIH's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to AMIH's ROE of +0.64%. Regarding short-term risk, CVSGF and AMIH have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, PNGB has a market cap of 4902.00. Regarding current trading prices, CVSGF is priced at $17.10, while PNGB trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas PNGB's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to PNGB's ROE of N/A. Regarding short-term risk, CVSGF is less volatile compared to PNGB. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, OBDP has a market cap of 652.00. Regarding current trading prices, CVSGF is priced at $17.10, while OBDP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas OBDP's P/E ratio is 0.00. In terms of profitability, CVSGF's ROE is +0.06%, compared to OBDP's ROE of N/A. Regarding short-term risk, CVSGF and OBDP have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, PXRB has a market cap of 82.00. Regarding current trading prices, CVSGF is priced at $17.10, while PXRB trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas PXRB's P/E ratio is -0.00. In terms of profitability, CVSGF's ROE is +0.06%, compared to PXRB's ROE of N/A. Regarding short-term risk, CVSGF and PXRB have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, CVSC has a market cap of 17.00. Regarding current trading prices, CVSGF is priced at $17.10, while CVSC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas CVSC's P/E ratio is 0.00. In terms of profitability, CVSGF's ROE is +0.06%, compared to CVSC's ROE of N/A. Regarding short-term risk, CVSGF is less volatile compared to CVSC. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, VLBI has a market cap of 11.00. Regarding current trading prices, CVSGF is priced at $17.10, while VLBI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas VLBI's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to VLBI's ROE of N/A. Regarding short-term risk, CVSGF is less volatile compared to VLBI. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, CPLT has a market cap of 2.00. Regarding current trading prices, CVSGF is priced at $17.10, while CPLT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas CPLT's P/E ratio is 0.00. In terms of profitability, CVSGF's ROE is +0.06%, compared to CPLT's ROE of N/A. Regarding short-term risk, CVSGF and CPLT have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, STON comparison data is unavailable. Regarding current trading prices, CVSGF is priced at $17.10, while STON trades at $3.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas STON's P/E ratio is -6.64. In terms of profitability, CVSGF's ROE is +0.06%, compared to STON's ROE of +0.48%. Regarding short-term risk, CVSGF is less volatile compared to STON. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, SPRJ comparison data is unavailable. Regarding current trading prices, CVSGF is priced at $17.10, while SPRJ trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas SPRJ's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to SPRJ's ROE of N/A. Regarding short-term risk, CVSGF is less volatile compared to SPRJ. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, NEBCU comparison data is unavailable. Regarding current trading prices, CVSGF is priced at $17.10, while NEBCU trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas NEBCU's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to NEBCU's ROE of +0.04%. Regarding short-term risk, CVSGF is less volatile compared to NEBCU. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, PLWN comparison data is unavailable. Regarding current trading prices, CVSGF is priced at $17.10, while PLWN trades at $590.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas PLWN's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.06%, compared to PLWN's ROE of N/A. Regarding short-term risk, CVSGF and PLWN have similar daily volatility (0.00).

CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVSGF stands at 1.23B. In comparison, TMX comparison data is unavailable. Regarding current trading prices, CVSGF is priced at $17.10, while TMX trades at $37.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVSGF currently has a P/E ratio of 47.50, whereas TMX's P/E ratio is 70.13. In terms of profitability, CVSGF's ROE is +0.06%, compared to TMX's ROE of +0.05%. Regarding short-term risk, CVSGF is less volatile compared to TMX. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.